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Since the description  of Lyt subclasses of T  lymphocytes in the mouse  (1-3), two 
subpopulations  of T  cells  in  man  have  been  defined  by antibodies  to heterologous 
membrane determinants  (4, 5). Those determinants restricted to suppressor/cytotoxic 
T  cells  (herein  termed  Leu-2)  belong  to  a  membrane  antigen  that  is  similar  in 
distribution,  structure,  and  function  to  the  mouse  Lyt-2,3  molecule  (6-8),  whereas 
those restricted to helper T  cells  (Leu-3) belong to a  single-chain membrane compo- 
nent of 55,000 tool wt  (6, 8).  Recent evidence that suggests that the Leu-2 molecule 
may act as an antigen receptor on alloantigen-activated cytotoxic T  cells (7), prompted 
us to examine the possibility that both Leu-2 and Leu-3 antigens are involved in the 
cognitive  functions  of their  respective  subsets.  Experiments  detailed  below  indicate 
that high concentrations of antibodies to Leu-2 and Leu-3 sites block the proliferative 
responses  of Leu-2 and  Leu-3 T  cells  in  the  mixed  leukocyte reaction  (MLR).  The 
implications  of these  findings  with  regard  to the  possible  roles of Leu-2 and  Leu-3 
antigen s in alloantigen recognition are discussed. 
Materials  and Methods 
Monoclonal Antibodies.  Mouse  monoclonal anti-Leu-1,  anti-Leu-2a, anti-Leu-3a,  and  anti- 
HLA-A2 antibodies  were  produced  by the  method of somatic cell  hybridization  and  were 
purified  from  BALB/c  ascites  fluid  by ammonium  sulfate  precipitation  and ,ion-exchange 
chromatography (anti-Leu antibodies) or size-exclusion  chromatography (anti-HLA-A2). All of 
these antibodies bind with similar affinity to human T cells and fail to lyse their target cell~ in 
the absence of complement. Anti-Leu- 1 (clone L17F 12) is an IgG2a antibody that binds to all 
peripheral  T  cells  (9). The  other  three  antibodies  are  of the  IgG1  isotype.  Anti-HLA-A2 
antibody  (designated  PA2.1)  was  generously  provided  by  Dr.  Peter  Parham  of Stanford 
University, Stanford, Calif. (10). 
Isolation of E-Rosetting and Nonrosetting Cells.  Peripheral blood mononuclear leukocytes were 
obtained from normal volunteers by Ficoll-Hypaque density-gradient centrifugation of fresh 
defibrinated  blood.  Populations  enriched  for T  and  non-T cells  were  prepared  by a  sheep 
erythrocyte rosetting technique in which 5  ×  10  n cells/ml were suspended  in 40%  fetal calf 
serum in phosphate-buffered saline (FCS-PBS) and mixed with an equal volume of 3% sheep 
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erythrocytes in  40%  FCS-PBS.  The  mixture  was  maintained  at  4°C  for  1 h.  It  was  then 
sedimented over a  second Ficoil-Hypaque gradient to separate the rosetted T  cells (E-RFC) 
from the nonrosetted (non-T) cells. Cells recovered from the rosetted pellet by treatment with 
hypotonic NH4CI solution contained <3% surface Ig  + cells on the basis of direct immunofluo- 
rescence. In addition, <3% of the T  cell-enriched fractions were monoeytes, based on staining 
with a-naphthyl acetate (11). The nonrosetting fraction was again treated with sheep erythro- 
cytes as above, and the resultant population consisted of 48-55% surface Ig  ÷ cells and 24-46% 
monocytes. 
Isolation of T  Cell Subsets.  To  obtain purified subsets of T  cells, a  panning technique as 
modified by Wysocki and Sato (12) was used to fractionate the E-RFC into Leu-2+/Leu-2  -  or 
Leu-3+/Leu-3  -  subpopulations. In this technique 2 ×  10~-3 ×  10  v unfractionated E-RFC were 
incubated with ~20 ~g of monoclonal antibody for 20 min. The cells were then washed twice 
in  5%  FCSopBS  and  poured  into  15-  ×  100-mm  plastic  petri  dishes  (Lab-Tek  Products, 
Naperville,  IL)  previously coated  with  affinity-purified goat  anti-mouse  IgG  (Tago,  Inc., 
Burlingame, Calif.) at  10 #g/ml in 0.05 Tris buffer (pH 9.5). The dishes were then incubated 
at 4°C for 2 h, after which, nonadherent cells were collected, and the dishes were gently washed 
five times with 1% FCS-PBS before recovery of bound cells by vigorous pipetting. When anti- 
Leu-2a was used as the first-stage incubating antibody, <5% of the unbound cells were Leu-2  + 
and >98% of the bound cells were Leu-2  + on the basis of analysis in a  fluorescence-activated 
cell sorter. Similar subset purity was achieved when anti-Leu-3a antibody was used as the first- 
stage incubating antibody. 
MLR.  Responder cells were obtained from individuals known to be HLA-A2  ÷ both on the 
basis of binding to monoclonal anti-HLA-A2 antibody and on the basis of typing by standard 
iymphocytotoxicity with alloantisera. Stimulator cells were obtained from HLA-A2- donors. 
MLR were performed in round-bottomed microtiter wells containing RPMI-1640 medium 
supplemented with 25 mM Hepes buffer, 2 mM glutamine, 100 U/ml of penicillin, 100 ~g/ml 
streptomycin, and  10% decomplemented pooled human serum. Triplicate cultures were incu- 
bated at 37°C in a  10% COs humidified atmosphere. Cultures consisted of 5 ×  104 responder 
T  cells, 5  ×  103-2.5  ×  104  allogeneic stimulator non-T  cells irradiated to  3,000  rad  (l~Cs 
Irradiator; J. L. Shepherd & Associates, Glendale, Calif.), and the indicated antibody in a total 
vol of 0.20  ml.  Proliferation was measured by addition of [SH]thymidine (1  #Ci/well)  18 h 
before harvesting with a MASH II apparatus (Microbiological Associates, Walkersville, Md.). 
Results 
Table I summarizes the effects of various monoclonal antibodies on the response of 
unseparated T  lymphocytes in MLR. As shown,  10/~g (final concentration, 50 #g/ml) 
of either anti-Leu-2a or anti-Leu-3a significantly inhibited  proliferation by T  cells 
responding  to  5  X  103  allogeneic non-T  cells.  Little or  no  inhibition of MLR  was 
produced by the same concentration of anti-Leu-1  or anti-HLA-A2 antibodies. The 
effect of anti-Leu-3a was somewhat  greater than  the effect of anti-Leu-2a, an obser- 
vation reproduced in five of six separate experiments. However, inhibition was never 
complete  and  was  diminished by either reducing  the concentration  of antibody or 
increasing the number of stimulator cells (Table I). 
Because  proliferation was  measured  on  the  7th  d  of culture,  the  effects of these 
antibodies might  have  been  a  result  of alteration of the proliferative kinetics. This 
was excluded by harvesting replicate cultures after varying periods of incubation. As 
shown  in Fig.  1A, suppression of the T  cell response by anti-Leu-2a or anti-Leu-3a 
was  greatest  on  days 5-7.  The same figure also shows  that  the inhibitory effects of 
these  antibodies were  additive.  Thus,  when  both  antibodies  were  present  in  high 
concentration, the response was almost abolished. 
To assess the effects of anti-Leu-2a and anti-Leu-3a antibodies on the response of 
isolated T  cell subsets, E-RFC were fractionated into Leu-2 and Leu-3 subpopulations 195 
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Proliferation induced by 
Antibody  ~g/culture  Background  Stimulator 1, No. cells:  Stimulator 2, No. cells: 
5X  10  a  2.5X  104  5X  103  2.5X  104 
None  137  18,867  37,233  23,870  52,840 
Ant  i-  Leu  - 1  10  201  20,166  35,519  24,955  50,373 
1  175  19,880  36,812  25,044  53,831 
Ant  i-  Leu  -2a  10  105  9,8635  33,104  12,4195  44,076 
1  116  14,040  39,619  26,812  53,301 
Anti-Leu-Sa  10  161  5,099§  29,586  8,514§  28,3615 
1  123  10,3695  33,911  12,3525  39,435 
Anti-HLA-A2  10  98  19,865  32,301  22,517  44,131 
1  110  16,194  34,455  20,532  42,718 
* 5 X 104 responder T cells from an HLA-A2  ÷ donor were cultured for 7 d with 5 x  10  s or 2.5 x  104 irradiated (3,000 rad) 
allogeneic non-T cells from two HLA-A2- donors. Results represent the mean of triplicate cultures in counts per minute. 
$ Inhibition significant at P <  0.05 by two-tailed t test. 
§ Inhibition significant at P<  0.01 by two-tailed t test. 
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TAnL~  I 
Inhibitory  Effects of Anti-Leu-2a and Anti-Leu-3a Antibodies  on T  Cell Proliferation  in MLR* 
INCUBATION TIME (DAYS) 
FIe.  1.  Kinetics of MLR  suppression by anti-Leu-2a and anti-Leu-3a antibodies. 5  X  104 unsep- 
arated T  cells (A), Leu-2 + cells (B), or Leu-3  + cells (C) were cultured with 5 ×  103 irradiated (3,000 
rad)  allogeneic non-T cells in the absence of added antibody (O)  or in the presence of 10 ~g anti- 
Leu-2a  (O),  10/lg anti-Leu-3a  (A), or  10 p,g of each antibody (I-q).  C~altures were begun on day 0 
and harvested on days 3, 5, 7, and  10.  Responses represent the mean of triplicate cultures +  1 SD. 
and incubated separately with allogeneic stimulator cells in the presence of specific 
antibody.  Fig.  1B and C  demonstrates that inhibition by these antibodies is limited 
to antibody-reactive cells. Near-complete inhibition of the response of isolated subsets 
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of retarded  or accelerated kinetics.  Although  the  results  shown were obtained with 
positively selected subsets  (i.e.,  Leu-2  + and Leu-3+), similar results were obtained by 
using  negatively  selected  subsets  (i.e.,  Leu-2-  and  Leu-3-  populations).  As  in  the 
response  by  unseparated  T  cells,  inhibition  of the  subset  responses  was  markedly 
diminished  when  lower  concentrations  of antibody  or  higher  numbers  of non-T 
stimulator cells were used (data not shown). Anti-Leu-1 and anti-HLA-A2 antibodies 
had no effect on the subset responses (data not shown). 
Discussion 
These results demonstrate that monoclonal anti-Leu-2a and anti-Leu-3a antibodies 
block proliferation in MLR of Leu-2 and Leu-3 T  cells, respectively. The failure of 
either  antibody  to  completely  inhibit  the  response  of  unfractionated  T  cells  is 
explained by the observation (Fig.  1 B and C) that both subsets proliferate independ- 
ently in response to alloantigen. Blocking is a result of the direct effect of antibody on 
responder T  cells, which bind the antibodies, rather than the non-T stimulator cells. 
Time-course experiments  ruled  out  the  possibility  that  inhibition  was  a  result  of 
alteration of MLR kinetics. Although it is possible that the inhibitory effects of anti- 
Leu-2a  and  anti-Leu-3a  could  result  from  destruction  of the  responding  cells  by 
antibody-dependent  cell-mediated  cytotoxicity  (13),  a  monoclonal  anti-HLA-A2 of 
the  same  subclass  (IgG1)  had  little  or  no  effect  on  the  response  of  HLA-A2  + 
individuals.  IgG2a  monoclonal  antibody  to  Leu-1,  an  antigen  distributed  on  all 
peripheral T  cells, also had no inhibitory effect on the MLR. Alternatively, our results 
might be explained by steric hindrance  of structures adjacent  to the Leu-2a and/or 
Leu-3a sites which  have functions critical to T  cell activation.  However, this would 
seem unlikely to occur on cells of both subsets. 
Because  blocking  by  both  Leu  antibodies  was  augmented  by  increasing  their 
concentration and decreasing the concentration of stimulator cells, it would seem that 
anti-Leu-2a and anti-Leu-3a compete with stimulator cell antigens for T  cell mem- 
brane sites which  are involved either  in  antigen  recognition  by T  cells or in  other 
events which lead to T  cell activation. At least in the case of the Leu-2 molecule, this 
possibility is strengthened by the observation that anti-Leu-2 antibodies inhibit killing 
by cytotoxic T cells in cell-mediated lympholysis (7). Moreover, experiments described 
elsewhere  suggest  that  different  histocompatibility  antigens  are  involved  in  the 
activation of Leu-2  and  Leu-3 T  cells. 1 In light  of those data,  the present  findings 
might be interpreted  as indicating  that  the Leu-2 and Leu-3 molecules function  as 
receptors for the target alloantigens of their respective subsets. 
Previous studies in mice have shown that antibodies to Lyt-2,3 sites block cytotox- 
icity by alloactivated T  cells  (14-18)  and  block proliferation  in  the MLR  (16,  17). 
The  tight  linkage  of genes  coding  for  Lyt-2,3  determinants  and  genes  coding  for 
immunoglobulin x chains, has therefore raised the possibility that part of the Lyt-2,3 
molecule is a clonally determined antigen receptor (19-21). Although this hypothesis 
may  be  relevant  to  the  functional  nature  of the  human  Leu-2  antigen,  which  is 
homologous to the Lyt-2,3 molecule (6-8), no mouse counterpart  to Leu-3 has been 
identified. 
i Engleman, E. G., C. J. Benike, F. C. Grumet, and R. L. Evans. Activation of human T  lymphocyte 
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Summary 
Two major subsets of human T  lymphocytes that are functionally analogous to the 
mouse Lyt-2  + and Lyt-2- subsets have been defined by their expression of two thymus- 
dependent  membrane  antigens,  Leu-2  and  Leu-3.  Leu-2+,3  -  cells  have suppressor/ 
cytotoxic  functions  and  Leu-2-,3 +  cells  have  helper  functions.  These  studies  were 
designed  to  determine  the  effects of adding  IgG1  monoclonal anti-Leu-2  and  anti- 
Leu-3  antibodies  to  the  mixed  leukocyte  reaction  (MLR).  At  high  concentrations, 
each  antibody  partially  inhibited  the  proliferative  response  of unseparated  T  cells 
and abolished the response of the isolated subset having the appropriate phenotype. 
An IgG1 monoclonal antibody to HLA-A2 and an IgG2a antibody to Leu-1, a pan-T 
antigen,  failed  to inhibit  the MLR. These results  suggest  that  the Leu-2 and  Leu-3 
antigens  may have  a  direct  role  in  the  mechanism  whereby T  cells  recognize  and 
respond to alloantigen. 
We thank Dr. F. Carl Grumet of Stanford University for HLA typing of the cells used in this 
study. 
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